Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223246 · ClinicalTrials.gov registry record · NA
Medication Education for Dosing Safety
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT03223246: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03223246 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03223246, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
Acetaminophen and ibuprofen are two of the most commonly used medication products among children \<12 years old, and these medications are frequently prescribed for patients leaving the emergency department (ED), but previous studies have shown that parents often leave the ED unsure of how to safely dose these medications at home. This study will be a randomized controlled trial of a brief medication safety intervention, and examining parental knowledge and implementation of appropriate weight-based dosing.
Interventions
- OTHER Additional teaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03223246
The ClinicalTrials.gov registry entry for NCT03223246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Additional teaching is the first listed.
NCT03223246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03223246 about?
NCT03223246 is a clinical study titled "Medication Education for Dosing Safety". Acetaminophen and ibuprofen are two of the most commonly used medication products among children \<12 years old, and these medications are frequently prescribed for patients leaving the emergency department (ED), but previous studies have shown that parents often leave the ED unsure of how to safely...
What is the current status of trial NCT03223246?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2017-10-01. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT03223246?
The interventions under investigation include: Additional teaching (OTHER).
Who is sponsoring clinical trial NCT03223246?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.